Low-Dose Cytarabine versus Best Supportive Care for Patients with Acute Myeloid Leukaemia Unfit for the Standard of Care: Egyptian Centre Experience
Background: Acute myeloid leukaemia (AML) in the elderly is not strong enough to tolerate aggressive chemotherapy. We conducted the present study to compare the efficacy and safety of low-dose cytarabine (LDAC) with best supportive care (BSC) in Egyptian patients. Method: A prospective randomized st...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Shiraz University of Medical Sciences
2021-07-01
|
| Seri Bilgileri: | Middle East Journal of Cancer |
| Konular: | |
| Online Erişim: | https://mejc.sums.ac.ir/article_47279_8523db7c604c18a7471b4718c84315fe.pdf |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|